课题基金 / 基金详情

IMSD at UC Davis

IMSD at UC Davis
加州大学戴维斯分校 IMSD
批准号:
10094065
负责人:
ALDRIN V. GOMES
金额:
$47.45万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-01 至 2025-01-31
关键词:

项目摘要

项目成果

ALDRIN V. GOMES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The overarching goal of our proposed IMSD at UC Davis Training Program is to increase diversity of the biomedical research workforce via increasing the number of diverse students that complete PhDs in biomedical-related science fields. For this, we propose to implement a comprehensive intervention program that has rigorous research & education activities specifically for first-year graduate students. We anticipate that our enrichment activities will increase diversity of the life science pipeline by facilitating successful advancement of UC Davis PhD students to the next step of their biomedical research career. We propose to select 10 graduate students per year to participate in this program, which has four major objectives. The first is to increase the number of diverse students awarded PhDs in life science disciplines. In alignment with this goal, we expect that (a) the rate of acceptance of underrepresented (UR), economically disadvantaged, and disabled students into the target graduate groups will not be less than the rate for students not in those categories; (b) the trainees’ oral and written communication skills will be enhanced; (c) the trainees’ selection for 2nd and 3rd year slots on other UC Davis T32 programs will be increased, further expanding their interdisciplinary vistas; (d) time to and success rate of IMSD Fellows in advancing to candidacy will be enhanced; and (e) at least 80% of the Fellows will complete their PhD. Our second major objective of the proposed IMSD Fellows program is enhancement of the mentor trainee relationship. This will be accomplished by (a) implementing an annual workshop on mentor-trainee relationships which will include advice from successful senior graduate students; (b) implementing/utilizing an annual IDP to improve productivity and clarity; and (c) having mentors take specialized mentor training workshops. Our third objective is to develop outreach/communication and career skills of the IMSD trainees via (a) implementing structured interaction with undergraduate UR, economically disadvantaged and/or disabled students, providing relevant role models for these undergraduates; b) mentoring of entering IMSD trainees by more senior R25 IMSD and IMSD T32 graduate students; and c) development of important career skills by implementing experiential learning opportunities. The fourth objective is to utilize program evaluations to continuously improve the program and provide expedient dissemination of the results. This will be done by (a) implementation of evaluations throughout the Training Program; (b) publishing our success and failures to enhance the effectiveness of other T32 programs;(c) annually revisit the program plan incorporating improvements suggested by program evaluations; and (d) creation of an outstanding IMSD website for diverse graduate students.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MARC at University of California, Davis
  • 批准号:
    10625326
  • 项目类别:
  • 资助金额:
    $50.11万
  • 财政年份:
    2020
  • 负责人:
    ALDRIN V. GOMES
  • 依托单位:
IMSD at UC Davis
  • 批准号:
    10553192
  • 项目类别:
  • 资助金额:
    $51.36万
  • 财政年份:
    2020
  • 负责人:
    ALDRIN V. GOMES
  • 依托单位:
MARC at University of California, Davis
  • 批准号:
    10404626
  • 项目类别:
  • 资助金额:
    $49.47万
  • 财政年份:
    2020
  • 负责人:
    ALDRIN V. GOMES
  • 依托单位:
IMSD at UC Davis
国内基金
海外基金
六君焦仙汤通过调节肠道菌群影响Trp/AhR通路治疗UC的作用机制研究
  • 批准号:
    2026JJ80334
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李振龙
  • 依托单位:
从肠道菌群-胆汁酸-内质网应激轴研究胃苓汤调控PERK-eIF2α-ATF4-CHOP通路干预脾虚湿盛证UC的机制
  • 批准号:
    2026JJ81066
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    蔡莹
  • 依托单位:
基于“去宛陈莝,精生形盛”探讨白芍七物颗粒通过CDK4/6-CCND1/2/3-ATM通路时序调控UC肠黏膜细胞周期与DNA损伤修复的机制研究
基于16S rDNA测序联合代谢组学探讨中药金汁对UC大鼠肠道菌群的影响
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    洪中华
  • 依托单位: